My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Craig Allen serves as Medical Director at Rushford and Vice President of Addiction Services at Hartford HealthCare. (Courtesy ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...

What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...

Obesity and drinking alcohol increase the risk for liver cancer, and coffee consumption decreases the risk, according to a new report called Diet, Nutrition, Physical Activity and Liver Cancer. The ...

The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. In 2024, Iowa had a rate of 498 cancer cases per 100,000 individuals annually, behind Kentucky (the ...

Another important consideration that is usually ignored is sleep. The body can be affected by the natural control of the ...

Among patients with steatotic liver disease (SLD), patients with alcohol-associated liver disease (ALD) carry the highest risk of cirrhosis, followed by those with metabolic dysfunction–associated ...

Many patients taking obesity and diabetes drugs like Ozempic and Wegovy have found its benefits go beyond weight loss. They've also lost their craving for alcohol or drugs. "I have heard ...